Clinical Trial Update: A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ZX008 for CDKL5 deficiency disorder; current status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cdkl5 Deficiency Disorder
• Drug-resistant Epilepsy
• Generalized Tonic-clonic Seizures
• Infantile Spasms

Drugs mentioned

• ZX008 (fenfluramine hydrochloride)

Snippet

Sponsor: Zogenix, Inc. | Conditions: CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure | Phase 3 | Status: ACTIVE_NOT_RECRUITING